 
    
        
            Yale Technologies 
      
      
      Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
    Search (Pitches)
Search (Pitches)
- 
B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastasesRanjit S. Bindra, M.D., Ph.D.
- 
Brain Endothelium-Targeted Therapy for Cerebral Cavernous MalformationsJaime Grutzendler, MD
- 
DNA Self-Activating Warheads (SAWs)Seth Herzon, PhD
- 
Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial PeptidesJose Gomez-Villalobos, MD, MS
- 
EDDIT: Early Drug Discovery for Targeted Protein DegradationHo-Joon Lee, PhD
- 
ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.Stephen Waxman, MD, PhD
- 
Novel treatment for hypertrophic and keloidal scarringChristopher G Bunick, MD/PhD
- 
A new class of selective GSK3B-inhibitors for refractory lymphoid malignanciesMarkus Müschen, MD, PhD
- 
Harnessing p53beta as a medical treatment of skin cancerChristine Ko, MD
- 
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indicationsDianqing (Dan) Wu, PhD
 
     
 
 
 
 
 
 
 
 
